TWST INVESTORS: February 10, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

SAN FRANCISCO, CA – (December 15, 2022) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP recommends that Twist Bioscience Corporation (“Twist” or the “Company”) investors who suffered losses from purchasing or otherwise acquiring Twist common stock (NASDAQ: TWST) between December 13, 2019 and November 14, 2022 contact our attorneys immediately regarding pending